Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Building the framework for standardized clinical laboratory reporting of next generation sequencing data for resistance-associated mutations in Mycobacterium tuberculosis complex.

Tornheim JA, Starks AM, Rodwell TC, Gardy JL, Walker TM, Cirillo DM, Jayashankar L, Miotto P, Zignol M, Schito M.

Clin Infect Dis. 2019 Mar 18. pii: ciz219. doi: 10.1093/cid/ciz219. [Epub ahead of print]

PMID:
30883637
2.

Enabling precision medicine via standard communication of HTS provenance, analysis, and results.

Alterovitz G, Dean D, Goble C, Crusoe MR, Soiland-Reyes S, Bell A, Hayes A, Suresh A, Purkayastha A, King CH, Taylor D, Johanson E, Thompson EE, Donaldson E, Morizono H, Tsang H, Vora JK, Goecks J, Yao J, Almeida JS, Keeney J, Addepalli K, Krampis K, Smith KM, Guo L, Walderhaug M, Schito M, Ezewudo M, Guimera N, Walsh P, Kahsay R, Gottipati S, Rodwell TC, Bloom T, Lai Y, Simonyan V, Mazumder R.

PLoS Biol. 2018 Dec 31;16(12):e3000099. doi: 10.1371/journal.pbio.3000099. eCollection 2018 Dec.

3.

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.

Ezewudo M, Borens A, Chiner-Oms Á, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J.

Sci Rep. 2018 Oct 18;8(1):15382. doi: 10.1038/s41598-018-33731-1.

4.

Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure.

Roversi S, Boschetto P, Beghe' B, Schito M, Garofalo M, Stendardo M, Ruggieri V, Tonelli R, Fucili A, D'Amico R, Banchelli F, Fabbri LM, Clini EM.

Multidiscip Respir Med. 2018 Oct 1;13:35. doi: 10.1186/s40248-018-0148-1. eCollection 2018.

5.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

6.

Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.

Beghé B, Fabbri LM, Garofalo M, Schito M, Verduri A, Bortolotti M, Stendardo M, Ruggieri V, Fucili A, Sverzellati N, Della Casa G, Maietti E, Clini EM, Boschetto P.

Respiration. 2019;97(3):223-233. doi: 10.1159/000492286. Epub 2018 Sep 11.

PMID:
30205380
7.

Forced expiratory volume in one second: A novel predictor of work disability in subjects with suspected obstructive sleep apnea.

Stendardo M, Casillo V, Schito M, Ballerin L, Stomeo F, Vitali E, Nardini M, Maietti E, Boschetto P.

PLoS One. 2018 Jul 19;13(7):e0201045. doi: 10.1371/journal.pone.0201045. eCollection 2018.

8.

Mycobacterial biomaterials and resources for researchers.

Hazbón MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA.

Pathog Dis. 2018 Jun 1;76(4). doi: 10.1093/femspd/fty042. Review.

PMID:
29846561
9.

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.

Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C, Andres S, Barbova A, Borbe-Reyes A, Chin DP, Cirillo DM, Colvin C, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Hussain A, Ismail N, Kamal SMM, Khanzada FM, Kimerling M, Kohl TA, Mansjö M, Miotto P, Mukadi YD, Mvusi L, Niemann S, Omar SV, Rigouts L, Schito M, Sela I, Seyfaddinova M, Skenders G, Skrahina A, Tahseen S, Wells WA, Zhurilo A, Weyer K, Floyd K, Raviglione MC.

Lancet Infect Dis. 2018 Jun;18(6):675-683. doi: 10.1016/S1473-3099(18)30073-2. Epub 2018 Mar 21. Erratum in: Lancet Infect Dis. 2018 Mar 27;:.

10.

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.

Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC.

Eur Respir J. 2017 Dec 28;50(6). pii: 1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec.

11.

Performance of the SAMBA I and II HIV-1 Semi-Q Tests for viral load monitoring at the point-of-care.

Goel N, Ritchie AV, Mtapuri-Zinyowera S, Zeh C, Stepchenkova T, Lehga J, De Ruiter A, Farleigh LE, Edemaga D, So R, Sembongi H, Wisniewski C, Nadala L, Schito M, Lee H.

J Virol Methods. 2017 Jun;244:39-45. doi: 10.1016/j.jviromet.2017.03.001. Epub 2017 Mar 6.

PMID:
28274744
12.

World TB Day 2017: Advances, Challenges and Opportunities in the "End-TB" Era.

Petersen E, Maeurer M, Marais B, Migliori GB, Mwaba P, Ntoumi F, Vilaplana C, Kim K, Schito M, Zumla A.

Int J Infect Dis. 2017 Mar;56:1-5. doi: 10.1016/j.ijid.2017.02.012. Epub 2017 Feb 21. No abstract available.

13.

Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action.

McNerney R, Clark TG, Campino S, Rodrigues C, Dolinger D, Smith L, Cabibbe AM, Dheda K, Schito M.

Int J Infect Dis. 2017 Mar;56:130-135. doi: 10.1016/j.ijid.2016.11.422. Epub 2016 Dec 13. Review.

14.

Tuberculosis eradication versus control.

Schito M, Hanna D, Zumla A.

Int J Infect Dis. 2017 Mar;56:10-13. doi: 10.1016/j.ijid.2016.11.007. Epub 2016 Nov 18.

15.

Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approaches.

Hanna D, Romero K, Schito M.

Int J Infect Dis. 2017 Mar;56:208-211. doi: 10.1016/j.ijid.2016.10.008. Epub 2016 Oct 24.

16.

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC.

Lancet Infect Dis. 2016 Oct;16(10):1185-1192. doi: 10.1016/S1473-3099(16)30190-6. Epub 2016 Jul 7.

17.

Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.

Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, Marais B, Schito M, Churchyard G, Swaminathan S, Hoelscher M, Zumla A.

Lancet Infect Dis. 2016 Apr;16(4):e34-46. doi: 10.1016/S1473-3099(16)00070-0. Review.

PMID:
27036358
18.

World TB Day 2016: reflections on the global TB emergency.

Zumla A, Schito M, Chakaya J, Marais B, Mwaba P, Migliori GB, Hoelscher M, Maeurer M, Wallis RS.

Lancet Respir Med. 2016 Apr;4(4):249-51. doi: 10.1016/S2213-2600(16)00066-7. Epub 2016 Mar 23. Review. No abstract available.

PMID:
27016869
19.

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.

Rhee SY, Jordan MR, Raizes E, Chua A, Parkin N, Kantor R, Van Zyl GU, Mukui I, Hosseinipour MC, Frenkel LM, Ndembi N, Hamers RL, Rinke de Wit TF, Wallis CL, Gupta RK, Fokam J, Zeh C, Schapiro JM, Carmona S, Katzenstein D, Tang M, Aghokeng AF, De Oliveira T, Wensing AM, Gallant JE, Wainberg MA, Richman DD, Fitzgibbon JE, Schito M, Bertagnolio S, Yang C, Shafer RW.

PLoS One. 2015 Dec 30;10(12):e0145772. doi: 10.1371/journal.pone.0145772. eCollection 2015.

20.

Biomarkers of oxidative-stress and inflammation in exhaled breath condensate from hospital cleaners.

Casimirri E, Stendardo M, Bonci M, Andreoli R, Bottazzi B, Leone R, Schito M, Vaccari A, Papi A, Contoli M, Corradi M, Boschetto P.

Biomarkers. 2016;21(2):115-22. doi: 10.3109/1354750X.2015.1118541. Epub 2015 Dec 9.

PMID:
26649641
21.

A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.

Schito M, Dolinger DL.

EBioMedicine. 2015 Oct 9;2(10):1262-5. doi: 10.1016/j.ebiom.2015.10.008. eCollection 2015 Oct. No abstract available.

22.

Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.

Schito M, Maeurer M, Kim P, Hanna D, Zumla A.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S95-101. doi: 10.1093/cid/civ608.

23.

Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update.

Graham SM, Cuevas LE, Jean-Philippe P, Browning R, Casenghi M, Detjen AK, Gnanashanmugam D, Hesseling AC, Kampmann B, Mandalakas A, Marais BJ, Schito M, Spiegel HM, Starke JR, Worrell C, Zar HJ.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S179-87. doi: 10.1093/cid/civ581.

24.

Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.

Starks AM, Avilés E, Cirillo DM, Denkinger CM, Dolinger DL, Emerson C, Gallarda J, Hanna D, Kim PS, Liwski R, Miotto P, Schito M, Zignol M.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S141-6. doi: 10.1093/cid/civ610.

25.

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.

Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D'Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S102-18. doi: 10.1093/cid/civ609.

26.

Towards host-directed therapies for tuberculosis.

Zumla A, Maeurer M; Host-Directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS.

Nat Rev Drug Discov. 2015 Aug;14(8):511-2. doi: 10.1038/nrd4696. Epub 2015 Jul 17.

PMID:
26184493
27.

Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.

Salamon H, Yamaguchi KD, Cirillo DM, Miotto P, Schito M, Posey J, Starks AM, Niemann S, Alland D, Hanna D, Aviles E, Perkins MD, Dolinger DL.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S50-7. doi: 10.1093/infdis/jiu816. Review.

28.

Target product profile of a molecular drug-susceptibility test for use in microscopy centers.

Denkinger CM, Dolinger D, Schito M, Wells W, Cobelens F, Pai M, Zignol M, Cirillo DM, Alland D, Casenghi M, Gallarda J, Boehme CC, Perkins MD.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S39-49. doi: 10.1093/infdis/jiu682. Review.

29.

Defining the needs for next generation assays for tuberculosis.

Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, Gilpin C, Boehme CC, Schito M, Kimerling M, Pai M.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S29-38. doi: 10.1093/infdis/jiu821. Review.

30.

Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.

Pai M, Schito M.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S21-8. doi: 10.1093/infdis/jiu803. Review.

31.

Chronic diseases are strongly associated with sickness absences in a sample of Italian public employees.

Casimirri E, Vaccari A, Schito M, Bonci M, Stendardo M, Stefanati A, Nardini M, Boschetto P.

Int J Occup Med Environ Health. 2014 Jun;27(3):343-54. doi: 10.2478/s13382-014-0256-x. Epub 2014 May 13.

32.

Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

Kaufmann SH, Lange C, Rao M, Balaji KN, Lotze M, Schito M, Zumla AI, Maeurer M.

Lancet Respir Med. 2014 Apr;2(4):301-20. doi: 10.1016/S2213-2600(14)70033-5. Epub 2014 Mar 24. Review.

PMID:
24717627
33.

Totally-drug-resistant tuberculosis: hype versus hope.

Maeurer M, Schito M, Zumla A.

Lancet Respir Med. 2014 Apr;2(4):256-7. doi: 10.1016/S2213-2600(14)70020-7. Epub 2014 Mar 24. No abstract available.

PMID:
24717619
34.

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ.

Lancet Infect Dis. 2014 Apr;14(4):327-40. doi: 10.1016/S1473-3099(13)70328-1. Review.

PMID:
24670627
35.

Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines.

Zumla AI, Schito M, Maeurer M.

Lancet Infect Dis. 2014 Apr;14(4):267-9. doi: 10.1016/S1473-3099(14)70028-3. No abstract available.

PMID:
24670623
36.

Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.

Sanchez AM, DeMarco CT, Hora B, Keinonen S, Chen Y, Brinkley C, Stone M, Tobler L, Keating S, Schito M, Busch MP, Gao F, Denny TN.

J Immunol Methods. 2014 Jul;409:117-30. doi: 10.1016/j.jim.2014.01.004. Epub 2014 Jan 19.

37.

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.

Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M.

Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Review.

38.

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.

Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A.

Lancet Infect Dis. 2013 May;13(5):436-48. doi: 10.1016/S1473-3099(13)70015-X. Epub 2013 Mar 24. Review.

39.

Drug-resistant tuberculosis: time for visionary political leadership.

Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A.

Lancet Infect Dis. 2013 Jun;13(6):529-39. doi: 10.1016/S1473-3099(13)70030-6. Epub 2013 Mar 24. Review.

40.

Tuberculosis biomarkers discovery: developments, needs, and challenges.

Wallis RS, Kim P, Cole S, Hanna D, Andrade BB, Maeurer M, Schito M, Zumla A.

Lancet Infect Dis. 2013 Apr;13(4):362-72. doi: 10.1016/S1473-3099(13)70034-3. Epub 2013 Mar 24. Review.

PMID:
23531389
41.

Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A.

Lancet Infect Dis. 2013 Apr;13(4):349-61. doi: 10.1016/S1473-3099(13)70008-2. Epub 2013 Mar 24. Review.

42.

Zero deaths from tuberculosis: progress, reality, and hope.

Zumla A, Kim P, Maeurer M, Schito M.

Lancet Infect Dis. 2013 Apr;13(4):285-7. doi: 10.1016/S1473-3099(13)70039-2. Epub 2013 Mar 24. No abstract available.

43.

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.

McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, Weyer K, Lawn S, Grobusch MP, Memish Z, Squire SB, Pantaleo G, Chakaya J, Casenghi M, Migliori GB, Mwaba P, Zijenah L, Hoelscher M, Cox H, Swaminathan S, Kim PS, Schito M, Harari A, Bates M, Schwank S, O'Grady J, Pletschette M, Ditui L, Atun R, Zumla A.

J Infect Dis. 2012 May 15;205 Suppl 2:S147-58. doi: 10.1093/infdis/jir860. Epub 2012 Apr 10. Review.

PMID:
22496353
44.

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.

Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, McHugh TD, Squire SB, Cox H, Ford N, McNerney R, Marais B, Grobusch M, Lawn SD, Migliori GB, Mwaba P, O'Grady J, Pletschette M, Ramsay A, Chakaya J, Schito M, Swaminathan S, Memish Z, Maeurer M, Atun R.

J Infect Dis. 2012 May 15;205 Suppl 2:S228-40. doi: 10.1093/infdis/jir858. Epub 2012 Apr 3.

PMID:
22476720
45.

Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis.

Schito M, Peter TF, Cavanaugh S, Piatek AS, Young GJ, Alexander H, Coggin W, Domingo GJ, Ellenberger D, Ermantraut E, Jani IV, Katamba A, Palamountain KM, Essajee S, Dowdy DW.

J Infect Dis. 2012 May 15;205 Suppl 2:S169-80. doi: 10.1093/infdis/jis044. Epub 2012 Mar 29.

46.

Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs.

Zumla A, Atun R, Maeurer M, Kim PS, Jean-Philippe P, Hafner R, Schito M.

J Infect Dis. 2012 May 15;205 Suppl 2:S141-6. doi: 10.1093/infdis/jir880. Epub 2012 Mar 22. No abstract available.

47.

Perspectives on introduction and implementation of new point-of-care diagnostic tests.

Palamountain KM, Baker J, Cowan EP, Essajee S, Mazzola LT, Metzler M, Schito M, Stevens WS, Young GJ, Domingo GJ.

J Infect Dis. 2012 May 15;205 Suppl 2:S181-90. doi: 10.1093/infdis/jis203. Epub 2012 Mar 7.

48.

Workshop summary: Novel biomarkers for HIV incidence assay development.

Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, Keele B, Shapiro S, McMichael A, Burns DN.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):532-9. doi: 10.1089/AID.2011.0332. Epub 2012 Feb 24.

49.

Pilot studies for development of an HIV subtype panel for surveillance of global diversity.

Manak M, Sina S, Anekella B, Hewlett I, Sanders-Buell E, Ragupathy V, Kim J, Vermeulen M, Stramer SL, Sabino E, Grabarczyk P, Michael N, Peel S, Garrett P, Tovanabutra S, Busch MP, Schito M.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):594-606. doi: 10.1089/AID.2011.0271. Epub 2012 Feb 24.

50.

Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.

Cheng-Mayer C, Huang Y, Gettie A, Tsai L, Ren W, Shakirzyanova M, Sina ST, Trunova N, Blanchard J, Jenkins LM, Lo Y, Schito ML, Appella E.

AIDS. 2011 Sep 24;25(15):1833-41. doi: 10.1097/QAD.0b013e32834a1d94.

Supplemental Content

Loading ...
Support Center